COVID-19 and severity of liver diseases: Possible crosstalk and clinical implications.
Imam MT, Almalki ZS, Alzahrani AR, Al-Ghamdi SS, Falemban AH, Alanazi IM, Shahzad N, Muhammad Alrooqi M, Jabeen Q, Shahid I.
Imam MT, et al. Among authors: alanazi im.
Int Immunopharmacol. 2023 Aug;121:110439. doi: 10.1016/j.intimp.2023.110439. Epub 2023 Jun 8.
Int Immunopharmacol. 2023.
PMID: 37315370
Free PMC article.
Review.